Sale-leaseback
Showing 28 - 29 out of 29
Apotex
$468 million of sale-leaseback capital used to finance a portion of a PE firm's buyout of global pharmaceutical company.
$468 million of sale-leaseback capital used to finance a portion of a PE firm's buyout of global pharmaceutical company.